TMPRSS2-ERG fusion protein activates a transcriptional program that contributes to prostate oncogenesis through upregulation of the expression of some key genes including MYC, EZH2 and SOX9 and repression of NKX3 expression. This evidence concerns the gene MYC and male reproductive organ cancer.